Literature DB >> 6603218

Uptake of bepridil into isolated ventricular myocytes. Retention by actin.

G Cramb, J W Dow.   

Abstract

Isolated rat ventricular myocytes accumulate large amounts of bepridil intracellularly. The mode of transport is uncertain but uptake is of such a magnitude as to mask possible sarcolemmal binding sites. Bepridil is tightly bound within myocytes, there being only a minimal efflux into bepridil-free medium. Purified F-actin binds bepridil in excess of 2 moles/mole actin, sufficient to account for the uptake of bepridil by myocytes incubated in 10 microM drug. At higher bepridil concentrations the amount transported into myocytes suggests that the drug may be distributed between actin-bound and cytoplasmic pools. Bepridil may alter cardiac contractility by a direct influence on the contractile filaments.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6603218     DOI: 10.1016/0006-2952(83)90548-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  11 in total

1.  Modulation of Na+-Ca2+ exchange in cardiac sarcolemmal vesicles by Ca2+ antagonists.

Authors:  T Hata; N Makino; H Nakanishi; T Yanaga
Journal:  Mol Cell Biochem       Date:  1988-11       Impact factor: 3.396

2.  Changing surface charge with salicylate differentiates between subgroups of calcium-antagonists.

Authors:  M Spedding
Journal:  Br J Pharmacol       Date:  1984-09       Impact factor: 8.739

3.  Electrophysiological effects of bepridil and its quaternary derivative CERM 11888 in closed chest anaesthetized dogs: a comparison with verapamil and diltiazem.

Authors:  J Leboeuf; J C Lamar; R Massingham; J Ponsonnaille
Journal:  Br J Pharmacol       Date:  1989-12       Impact factor: 8.739

4.  Binding of bepridil to isolated rat heart mitochondria.

Authors:  J M Schneider; A Younes
Journal:  Basic Res Cardiol       Date:  1989 Nov-Dec       Impact factor: 17.165

5.  Calcium channel effectors are potent non-competitive blockers of acetylcholine receptors.

Authors:  L P Adam; E G Henderson
Journal:  Pflugers Arch       Date:  1990-07       Impact factor: 3.657

6.  Comparative effects of bepridil, its quaternary derivative CERM 11888 and verapamil on caffeine-induced contracture in ferret hearts.

Authors:  J Leboeuf; C Leoty; J C Lamar; R Massingham
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

7.  Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).

Authors:  E Barron; R J Marshall; M Martorana; E Winslow
Journal:  Br J Pharmacol       Date:  1986-11       Impact factor: 8.739

Review 8.  Bepridil. A review of its pharmacological properties and therapeutic use in stable angina pectoris.

Authors:  L M Hollingshead; D Faulds; A Fitton
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

9.  Effects of selective channel blocking agents on contractions and action potentials in K+-depolarized guinea-pig atria.

Authors:  J Brown; R J Marshall; E Winslow
Journal:  Br J Pharmacol       Date:  1985-09       Impact factor: 8.739

10.  Stereoisomers of calcium antagonists discriminate between coronary vascular and myocardial sites.

Authors:  F T van Amsterdam; J Zaagsma
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-02       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.